Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease

Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04212572

Acronym

MASAÏ

Enrollment

242

Registered

2019-12-27

Start date

2019-11-20

Completion date

2020-05-20

Last updated

2019-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary sjögren's Syndrome

Keywords

Primary sjögren's syndrome, ultrasonography, salivary glands, auto-immune disease

Brief summary

Salivary gland ultrasonography is identified as a valuable diagnostic tool and potential criteria item for disease classification of sjögren's syndrome and evaluate evolution of parenchyma. The investigators have to include 242 patients. The objective is to evaluate the modification of ultrasonographic abnormalities according to disease in primary Sjögren syndrome.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male or female patient ≥ 18 years * Primary sjögren syndrome according of age to 2002 or 2016 classification criteria

Exclusion criteria

* Secondary sjögren syndrome

Design outcomes

Primary

Measure	Time frame	Description
Presence or absence of parenchymal abdnormalities.	inclusion	Presence or absence of parenchymal abdnormalities. Scored following a standardized fill and according to disease duration

Secondary

Measure	Time frame	Description
Parenchymal abnormalities according to disease activity	inclusion	Ultrasonography parenchymal abnormalities of salivary gland

Countries

France

Contacts

Primary ContactValerie DEVAUCHELLE

valerie.devauchelle-pensec@chu-brest.fr2 98 34 72 64

Outcome results